2020 Original Papers / 2020 原著論文
- Nagumo, Y.; Ueta, Y.; Nakayama, H.; Osaki, H.; Takeuchi, Y.; Uesaka, N.; Kano, M.; Miyata, M.
“Tonic GABAergic inhibition is essential for nerve injury-induced afferent remodeling in the somatosensory thalamus and ectopic sensations”
Cell Reports 2020, 31, 107797. (web) - Nagumo, Y.; Katoh, K.; Iio, K.; Saitoh, T.; Kutsumura, N.; Yamamoto, N.; Ishikawa, Y.; Irukayama-Tomobe, Y.; Ogawa, Y.; Baba, T.; Tanimura, R.; Yanagisawa, M.; Nagase, H.
“Discovery of attenuation effect of orexin 1 receptor to aversion of nalfurafine: Synthesis and evaluation of D-nor-nalfurafine derivatives and analyses of the three active conformations of nalfurafine”
Bioorg. Med. Chem. Lett. 2020, 30, 127360. (web) - Kutsumura, N.; Koyama, Y.; Saitoh, T.; Yamamoto, N.; Nagumo, Y.; Miyata, Y.; Hokari, R.; Ishiyama, A.; Iwatsuki, M.; Otoguro, K.; Ōmura, S.; Nagase, H.
“Structure-Activity Relationship between Thiol Group-Trapping Ability of Morphinan Compounds with a Michael Acceptor and Anti-Plasmodium falciparum Activities”
Molecules 2020, 25, 1112. (web) (Invited Paper) - Saitoh, T.; Seki, K.; Nakajima, R.; Yamamoto, N.; Kutsumura, N.; Nagumo, Y.; Irukayama-Tomobe, Y.; Ogawa, Y.; Ishikawa, Y.; Yanagisawa, M.; Nagase, H.
“Essential structure of orexin 1 receptor antagonist YNT-707, part V: Structure-activity relationship study of the substituents on the 17-amino group”
Bioorg. Med. Chem. Lett. 2020, 30, 126893. (web) - Miyata, Y.; Hasegawa, N.; Nagase, H.; Kutsumura, N.; Nagatomi, R.; Nakamura, K.; Majima, T.
“Medical and Social Countermeasures for Tokyo Olympic in 2021”
J. Phys. Fitness Sports Med. 2020, 9, 344. (web)
